Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks. [electronic resource]
Producer: 20171024Description: 1027-35 p. digitalISSN:- 1935-5548
- Adult
- Blood Glucose -- metabolism
- Body Weight
- Diabetes Mellitus, Type 1 -- complications
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Glucagon -- metabolism
- Humans
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- therapeutic use
- Insulin -- therapeutic use
- Liraglutide -- therapeutic use
- Male
- Middle Aged
- Obesity -- complications
- Overweight -- complications
- Postprandial Period
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.